Site Newsletter 02/13/2017

Table of Contents
  
REPRIEVE Trial Status: February 13th 
 2782 participants are enrolled
 236 participants are in screening
107 sites are open for enrollment
 26 sites have enrolled at least 1 participant in the past week
  32 sites have screened at least 1 participant in the past week
REPRIEVE Announcements

As April approaches don't forget our important goal of reaching 50% of REPRIEVE's total enrollment.

Less than 500 participants need to be enrolled to reach this goal, if at least 50 participants are enrolled each week we will reach this major milestone by mid-April!.
Welcome!!!
A warm welcome to the newest sites open for enrollment
Gaborone ClRS
University of Maryland
Petersen HIV Clinic, University of Arizona
Hospital Nossa Senhora da Conceicao CRS
Community AIDS Network/Comprehensive Care Clinic
School of Medicine, Federal University of Minas Gerais
Thank You to All Sites Enrolling Participants Week of 02/06/2017!
Thai Red Cross AIDS Research Center
Chiang Mai University HIV Treatment CRS
Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS
Alabama CRS
Northwestern University CRS
Whitman-Walker Health CRS
Wits Helen Joseph Hospital CRS (Wits HJH CRS)
Family Clinical Research Unit
Massachusetts General Hospital (MGH) CRS
Johns Hopkins University CRS
Weill Cornell Chelsea CRS
Vanderbilt Therapeutics (VT) CRS
UCSF HIV/AIDS CRS
SOWETO
University of Southern California CRS
University of Cape Town Lung Institute
UT Southwestern
Denver Public Health
Orlando Immunology Center CRS
Georgetown University CRS (GU CRS)
Wake Forest University
Duke University Medical Center
Mount Sinai Clinical and Translational Research Center CRS
Boston Medical Center
Abbott Northwestern Hospital
School of Medicine, Federal University of Minas Gerais CRS
 
FAQ
Q. Does any historical diagnosis of cirrhosis (even if current testing shows fibrosis without cirrhosis) exclude a participant from REPRIEVE? 
  • If current testing shows fibrosis without cirrhosis, we ask the research sites and site investigators to use their clinical judgment
  • If the research site/site investigator decides that a participant no longer has cirrhosis and therefore is eligible for the study, we ask the site PI to note this in the source documentation​
New
CRF
, CRF, CRF, CRF, CRF, CRF, CRF
New Form! DMW0025 - Gender Identity V1.00
  • This CRF is for the collection of Gender Identity
  • Information collected on this CRF is considered demographic data, already collected on all ACTG and other NIH network studies and does not modify the protocol.
  • For newly enrolling participants, complete the DMW0025 at study entry
  • For participants currently enrolled, complete the DMS0025 at next study visit.
  • This CRF only needs to be collected once!
  • It is located in the PRN visit in OpenClinica

Social Media Messages for Heart Month 




February is Heart Month. We have several messages your site can use on Twitter, Facebook,etc to promote REPRIEVE this month*. Check them out!  

*Please submit for approval as per your local IRB/EC requirements

REPRIEVE Events at CROI

Investigator's Meeting @ CROI 2017

When:  Wednesday, February 15th 12:15-1:45 PM PT
Where: Princessa Ballroom, Floor 1, Grand Hyatt, 721 Pine Street, Seattle, WA

If you have not registered yet, please email Laura Sanchez.  
 
REPRIEVE Office Hours
If you cannot make the investigator's meeting or you would like to meet with the REPRIEVE team in an informal setting, please stop by the REPRIEVE office hours!

When:  Wednesday, February 15th: 6:00 PM PT
Where:  Loulay, 600 Union Street, only 3 minutes walk from the Washington State Convention Center, click here for a map!
February is Heart Month
Take Action to Raise Awareness About HIV and Heart Health
Heart Month is an excellent time to spread the word about the importance of REPRIEVE to prevent heart disease among people living with HIV

Below are some ideas to raise awareness about HIV and Heart Health during February:
  • Organize an informational table in your clinic or community.
    • Click here to read an example from the MGH ACTG CRS.
  • Organize an HIV and Heart Health presentation for patients at your clinic or provide a presentation at an HIV service organization near you.  
  • Contact your local media or work with your press offic and ask if they might be interested in writing an article about HIV and heart disease.
The REPRIEVE Clinical Coordinating Center has slide presentations, media pitches, and many other resources you might find helpful to promote REPRIEVE during Heart Month; email Laura Sanchez, REPRIEVE Coordinator, to see how we may be of assistance to you and your team.
Order a FREE REPRIEVE Recruitment Materials Kit!

In honor of Heart Month and the opportunity to promote REPRIEVE in your community, we are providing a Free REPRIEVE Recruitment Materials Kit to all sites, even if your site has ordered one previously!

Between January 23rd and February 28th, 2017 order a Free REPRIEVE Recruitment Materials Kit for your site, click here for instructions on how to access the portal if you have not already used this resource.* Even if you have already ordered a kit, this opportunity is available again!

*Materials in the portal are available in English. If you require Spanish, French or Portuguese, please email Laura Sanchez at lsanchez12@partners.org.
REPRIEVE is in the News

REPRIEVE was recently featured in:
Save the Date! 
This webinar is intended for patients, study participants, peer advocates, case workers, social workers, and anyone else who wants to know more about heart disease risk in HIV and how to stay heart healthy. Please share this educational webinar widely! We have a flyer that you can print or post online

REPRIEVE (A5332):  Are you up to date? 

For A5332 please use
Protocol: 
Version 3.0 dated 01/28/2016 
Clarification Memo #1 dated 04/04/2016
Clarification Memo #2 dated 04/12/2016 (corrects an error in CM #1)
Clarification Memo #3 dated 12/27/2016
Letter of Amendment, Version 3.0 #1 dated 08/17/16
MOPS:
Version 3.0, revision 1, dated 09/09/16
A5332 LPC for ACTG Sites:
Version 3.0 dated 01/04/2017
A5332 LPC for Non-ACTG Sites:
Version 3.0 dated 01/04/2017


These documents are on the A5332 PSWP

REPRIEVE Mechanistic Substudy (A5333s):  Are you up to date? 

For A5333s please use
Protocol: Version 3.0 dated 01/28/2016
MOPS: Version 3.0 dated 09/02/2016
A5333s LPC : Version 3.0 dated 01/04/2017  


These documents are on the A5333s PSWP
For future reference, all newsletters are available on the REPRIEVE Website

We welcome suggestions and ideas for upcoming newsletters. Please submit any comments or suggestions to the REPRIEVE News Team at reprieve.news@fstrf.org.
 
Share
Tweet
Forward






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Massachusetts General Hospital · 5 Longfellow Place · Boston, MA 02214 · USA

Email Marketing Powered by Mailchimp